retatrutide phase 2 trial weight loss is generating a lot of buzz in the medical world—and for good reason. As research continues, many experts believe it could represent the next generation of metabolic health treatments Results of a new medication,

In six to twelve months, generic Saxenda will likely be another affordable weight-loss medication

Cardiovascular outcomes A total of 52 meta-analyses (covering 141 outcomes) evaluated GLP-1 RAs for cardiovascular outcomes (Fig

[DOI] [PMC free article] [PubMed] [Google Scholar] 64.Altimmune Presents Data from Phase 2 MOMENTUM Trial of Pemvidutide in Obesity during Oral Presentation at the American Diabetes Association

He L, Wang J, Ping F et al (2022) Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials

The NHS describes the typical symptoms of a lower UTI (affecting the bladder, also known as cystitis) as: A burning or stinging sensation when passing urine Needing to urinate more frequently or urgently than usual Urine that appears cloudy, dark, or has an unusual smell Pain or pressure in the lower abdomen or pelvis Feeling generally unwell or fatigued Full symptom information is available on the NHS UTI page

Starting with the lowest approved dose and increasing slowly often helps minimize adverse reactions